Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Avalyn Pharma logo

Avalyn Pharma

Recent Finacing

Series D

Recent Raise

$100M

Avalyn Pharma is a clinical-stage biopharma developing inhaled reformulations of approved antifibrotic drugs for targeted pulmonary delivery, advancing AP01, AP02, and a fixed-dose combination through clinical trials and manufacturing.

Founded 2011
Washington, United States
11-50
Private
avalynpharma.com
PitchBook

Highlights

Focus Areas

Biopharma
Biotechnology
Medical
Pharmaceutical

Recent Investors

SR One logo
Norwest Venture Partners logo
Wellington Management logo
Pivotal bioVenture Partners logo
Eventide Asset Management logo
T. Rowe Price Associates logo
F-Prime Capital logo
Novo Holdings logo
Rock Springs Capital logo
Catalio Capital Management logo
Vida Ventures logo
Surveyor Capital logo

Financials

$275M

Total Raised

2

Funding rounds

16

Investors


Team

Upgrade to view the team

See the team members at Avalyn Pharma.